fluorodeoxyglucose f18 has been researched along with lithium in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, M; Ecker, S; Gann, H; Riemann, D; Voderholzer, U; Weske, G | 1 |
| Bartenstein, P; Dahmen, N; Tonn, P | 1 |
| Celi, FS; Cochran, CS; Davis, JL; Hughes, M; Merino, MJ; Reynolds, JC; Wolff, EF | 1 |
| Bascuñana, P; Delgado, M; García-García, L; Gomez, F; Hernández-Martín, N; Pozo, MÁ; Rosa, RF; Silván, Á | 1 |
1 review(s) available for fluorodeoxyglucose f18 and lithium
| Article | Year |
|---|---|
Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer.
Topics: Abdominal Pain; Adult; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Hypothyroidism; Iodine Isotopes; Lithium; Mutation; Ovarian Cysts; Ovarian Neoplasms; Proto-Oncogene Proteins B-raf; Teratoma; Thyroglobulin; Thyroid Neoplasms; Thyroxine; Treatment Outcome | 2010 |
3 other study(ies) available for fluorodeoxyglucose f18 and lithium
| Article | Year |
|---|---|
Neurobiological findings before and during successful lithium therapy of a patient with 48-hour rapid-cycling bipolar disorder.
Topics: Adult; Affect; Antimanic Agents; Bipolar Disorder; Fluorodeoxyglucose F18; Humans; Hydrocortisone; Lithium; Male; Polysomnography; Psychiatric Status Rating Scales; Radiopharmaceuticals; Saliva; Sleep; Thyrotropin; Tomography, Emission-Computed | 2002 |
[Lithium intoxication mimics Alzheimer's disease in PET and clinical findings].
Topics: Aged; Alzheimer Disease; Brain; Diagnosis, Differential; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Lithium; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
A Single High Dose of Flufenamic Acid in Rats does not Reduce the Damage Associated with the Rat Lithium-Pilocarpine Model of Status Epilepticus but Leads to Deleterious Outcomes.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Epilepsy; Epilepsy, Temporal Lobe; Flufenamic Acid; Fluorodeoxyglucose F18; Gliosis; Glucose; Hippocampus; Lithium; Male; Neuroinflammatory Diseases; Pilocarpine; Rats; Rats, Sprague-Dawley; Status Epilepticus | 2023 |